Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | AKT1 | P31749 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19300441 | 0.81 | AKT1 (0.38) | MEN1KMT2ALMNAMAPK1HTT | |
| SCHEMBL22071895 | 0.81 | LMNA (0.36) | MEN1KMT2ALMNAMAPK1HTT | |
| SCHEMBL24884816 | 0.78 | AKT1 (0.35) | MEN1KMT2ALMNAMAPK1HTT | |
| SCHEMBL21229634 | 0.77 | MAPT (0.43) | MEN1KMT2ALMNAMAPK1L3MBTL1 | |
| SCHEMBL22036325 | 0.77 | LMNA (0.36) | MEN1KMT2ALMNAMAPK1HTT | |
| SCHEMBL20908860 | 0.76 | MEN1 (0.32) | MEN1KMT2ALMNAMAPK1HTT | |
| SCHEMBL21253891 | 0.75 | AKT1 (0.37) | MEN1KMT2AMAPK1AKT1ATM | |
| SCHEMBL19446503 | 0.74 | CES2 (0.37) | MEN1KMT2AMAPK1NFE2L2CA12 | |
| SCHEMBL19101609 | 0.73 | TSHR (0.32) | MEN1KMT2ALMNAMAPK1L3MBTL1 | |
| SCHEMBL24520419 | 0.73 | NFE2L2 (0.52) | MEN1KMT2AMAPK1HTTAKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10177316-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10177316-B2 | Organic electroluminescent materials and devices | OSBP, OSBPL3, OSBP2 | MEN1 4195/4885KMT2A 4410/4885LMNA 3670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.